Searched for
GENERIC AIDS DRUGS
Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Easy access to weight-loss drugs rings alarm bells among doctors, authorities; regulators step inWeight-loss drugs are being sold without prescriptions in India. This is causing alarm among doctors and authorities. People are buying the...
- India should reject efforts weakening access to generic drugsMSF urged Modi to defend India's lifeline to South Africa and developing countries through affordable versions of new medicines.
- 80% drugs to combat AIDS supplied by India: JP NaddaThe UN General Assembly adopted a new political declaration that emphasised on the critical importance of affordable medicines to combat th...
- Doctors: Patents keep HIV drugs too pricy to useDoctors Without Borders warned today that rising intellectual property rights are blocking the generic production of newer drugs to treat H...
- Ranbaxy drugs are 'safe and efficacious': South African regulatorGeneric drugs distributed in South Africa by Indian pharmaceutical giant Ranbaxy are "safe" and "efficacious", the country's regulator body...
- Termination of proposed merger with Taro positive for Sun Pharma: BarclaysBarclays feels that the termination of proposed merger with Taro eliminates a major uncertainty on Sun’s future direction.
- Ranbaxy refusing legal costs: US Drugstore chain Rite AidA retailer of Ranbaxy drugs in US has filed a complaint alleging that Ranbaxy has refused to cover legal costs and losses the retailer has ...
- Gilead Sciences Inc allows 4 Indian pharmaceutical companies Ranbaxy Laboratories, Matrix Laboratories, Hetero Drugs and Strides Arcolab to sell HIV GenericsRanbaxy Laboratories, Matrix Laboratories, Hetero Drugs and Strides Arcolab can make and sell the three drugs in 100 countries by paying ro...
- India to WIPO chief: MNCs working against Indian drug firmsIndia on Wednesday complained to the UN intellectual property rights body, WIPO, that some multinational firms have launched campaign again...
- SC asks Chennai patent office to hear RocheThe SC asked the Chennai patent office to hear and take a final view for all post-grant oppositions for a patent it had granted to Swiss co...
- SC asks Roche not to pursue Cipla case until patent examinationThe Supreme Court (SC) has asked Swiss company Roche not to pursue the patent violation case against the generic version of Cipla’s anti-in...
- Indian firms get lion's share in US anti-AIDS fundingAurobindo Pharma, Cipla and Ranbaxy, have received a lion's share of over 85 per cent in the US government's latest fiscal funding for AIDS...
- US govt okays generic versions of insomnia drugThe first generic versions of the insomnia drug Ambien have won US government approval.
- India to provide costly 'second-line' AIDS drugsIndia could start providing expensive "second-line" drugs to AIDS patients as early as next year, the country's top official for controllin...
- Cipla lends support to anti-patent driveDomestic pharma major Cipla is opposing US-based biotech major Gilead Sciences’ patent application in India for anti-AIDS drug Viread.
- Activists delivers coffin to Novartis over Indian caseThe groups said India's ability to manufacture low cost generic versions of newer medicines would be threatened if Norvatis won the suit.
- Gilead’s anti-AIDS drug to cost $1 a day hereViread, the largest selling anti-HIV/AIDS drug in the United States, will be available to patients in India at a special price equivalent o...
- National pharma policy to be final in 2 wksThe national pharmaceutical policy is likely to be finalised in the next 2 weeks. Speaking on the sidelines of the Pharmexcil India-CIS sum...
Load More
